Skip to main content
Bildspel: 

New number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, July 30[th], 2021, Moberg Pharma AB (OMX: MOB) announced that the total number of common shares in the company has increased to 45,511,425. The 910,000 newly issued shares are held by the company to secure its commitments under incentive programmes.

As per July 30th, 2021, the total number of shares in Moberg Pharma AB (publ) amounts to 45,511,425. All shares are common shares. The total number of votes are 45,511,425. The increase in the number of shares and votes results from an issue of 910,000 class C shares. The newly issued class C shares have been repurchased and, by virtue of the conversion clause in the articles of association, converted to common shares. As per July 30th, 2021, the company holds 1,464,746 common shares. The shares are intended to ensure fulfilment of commitments under incentive programmes.

For additional information, please contact:
Anna Ljung, CEO, telephone: +46 707 66 60 30, e-mail: anna.ljung@mobergpharma.se

Mark Beveridge, VP Finance, telephone: +46 76 - 805 82 88, e-mail: mark.beveridge@mobergpharma.se

About this information
The above information has been made public in accordance with the Swedish Financial Instruments Trading Act. The information was released for public distribution on July 30th, 2021, at 8:00 am CET.

About Moberg Pharma, www.mobergpharma.com
Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company’s main asset, MOB-015, is a novel topical treatment for onychomycosis. Data from phase 3 clinical trials in more than 800 patients for MOB-015 indicate that the product has the potential to become the future market leader in onychomycosis. Moberg Pharma has agreements with commercial partners in place in Europe and Japan, among others, and the company's intention is to submit a registration application during the second half of 2021 in Europe. Moberg Pharma is headquartered in Stockholm and the company’s shares are listed on the Small Cap list of the Nasdaq Stockholm (OMX: MOB).